Vortrag am FONDS professionell KONGRESSAbaris Biotech.Opportunities A CHF
| MVD-Fonds Rating | EDA |
|---|---|
| Kein Rating vorhanden | - |
ISIN: LU2210124454 | WKN: A2QAAT
KAG: Hauck & Aufhäuser
NAV: 49,82 CHF am 04.07.2022
Portfolio
Watchlist
KursalarmChart
Kennzahlen Abaris Biotech.Opportunities A CHF
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +8,89% | -41,16% | -53,80% | - | - | - | -55,46% |
| Volatilität | +56,83% | +59,21% | +47,62% | - | - | - | +42,36% |
| Sharpe Ratio | +3,20 | -1,11 | -1,13 | - | - | - | -0,96 |
| Bester Monat | - | +5,97% | +5,97% | - | - | - | +8,68% |
| Schl. Monat | - | -24,37% | -24,37% | - | - | - | -24,37% |
| Max. Verlust | -14,48% | -50,40% | -60,38% | - | - | - | -67,34% |
Monatsperformance Abaris Biotech.Opportunities A CHF
| 2022 | 2021 | ||||
| Januar | -24,37% | +7,36% | |||
| Februar | +3,22% | -0,50% | |||
| März | +2,84% | -8,86% | |||
| April | -15,97% | +1,52% | |||
| Mai | -17,23% | -9,24% | |||
| Juni | +5,97% | +8,68% | |||
| Juli | +0,04% | -9,55% | |||
| August | - | +4,95% | |||
| September | - | -3,70% | |||
| Oktober | - | -0,39% | |||
| November | - | -14,11% | |||
| Dezember | - | -0,80% | |||
| Gesamt | -40,81% | -24,36% |
